Home » Stocks » Alphatec Holdings

Alphatec Holdings, Inc. (ATEC)

Stock Price: $5.88 USD -0.16 (-2.57%)
Updated Aug 14, 2020 3:59 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 377.78M
Revenue (ttm) 121.30M
Net Income (ttm) -68.13M
Shares Out 64.30M
EPS (ttm) -1.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $5.88
Previous Close $6.03
Change ($) -0.16
Change (%) -2.57%
Day's Open 5.95
Day's Range 5.81 - 6.05
Day's Volume 137,613
52-Week Range 2.19 - 7.93

More Stats

Market Cap 377.78M
Enterprise Value 414.68M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 64.30M
Float 47.51M
EPS (basic) -1.12
EPS (diluted) -1.12
FCF / Share -1.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.55M
Short Ratio 11.12
Short % of Float 7.61%
Beta 1.94
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 3.11
PB Ratio 15.85
Revenue 121.30M
Operating Income -55.06M
Net Income -68.13M
Free Cash Flow -64.92M
Net Cash -36.90M
Net Cash / Share -0.57
Gross Margin 63.97%
Operating Margin -45.39%
Profit Margin -56.20%
FCF Margin -53.52%
ROA -17.83%
ROE -169.87%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 5
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$9.80*
(66.81% upside)
Low
9.00
Current: $5.88
High
13.00
Target: 9.80
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue11391.69102120134155205196198172
Revenue Growth23.7%-9.87%-15.39%-10.52%-13.09%-24.47%4.3%-0.72%15.21%-
Gross Profit77.5963.2468.2276.1388.02110124124117113
Operating Income-47.28-22.44-9.00-15.38-1761.49-73.43-9.84-24.52-11.79
Net Income-57.00-28.98-2.29-29.93-179-12.88-82.23-15.46-22.18-14.36
Shares Outstanding52.2335.3212.798.588.308.118.027.527.406.55
Earnings Per Share-1.09-1.20-1.08-3.49-21.53-1.90-10.20-2.04-3.00-2.16
Operating Cash Flow-33.12-25.61-8.73-9.9610.12-20.277.8111.5913.41-14.83
Capital Expenditures-13.03-6.17-6.50-8.90-12.25-11.30-14.35-15.65-8.21-14.03
Free Cash Flow-46.15-31.77-15.22-18.86-2.12-31.57-6.55-4.055.20-28.86
Cash & Equivalents47.1129.0522.4719.598.6524.1421.3522.2420.6723.17
Total Debt56.1845.5841.0746.2180.2282.6754.9041.6728.2034.18
Net Cash / Debt-9.06-16.52-18.61-26.61-71.58-58.54-33.56-19.43-7.53-11.01
Assets17012984.6694.19146345366382367377
Liabilities126112111136183196194136121111
Book Value43.6317.57-26.66-41.50-36.58149172246245266
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Alphatec Holdings, Inc.
Country United States
Employees 227
CEO Patrick S. Miles

Stock Information

Ticker Symbol ATEC
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: ATEC
IPO Date June 2, 2006

Description

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to meet the surgeon's needs and to maximize patient outcomes; LLICO access system, a minimally invasive posterior thoracolumbar access system; Invictus Spinal Fixation System, a comprehensive thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep designed to improve surgical efficiency without compromising accuracy. It also provides Arsenal spinal fixation system intended for posterior, non-cervical fixation in skeletally mature patients for treating degenerative disc disease, spondylolisthesis, fracture or dislocation, spinal stenosis, curvatures, tumor, pseud arthrosis, and failed previous fusion; zodiac degenerative spinal fixation system, a comprehensive spinal system used to address degenerative spinal conditions and deformity correction; OsseoScrew system to restore the integrity of the spinal column; trestle luxe anterior cervical plate system; and solanas posterior cervico/thoracic fixation system and avalon occipital plate. In addition, the company offers IdentiTi Porous Ti and Transcend Lateral Interbody Implants; Battalion PC; Novel SD; Solus Anterior Lumbar Interbody Fusion System. Further, it is developing EOS imaging products. Additionally, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.